Additive effects of aminoglutethimide testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase
- 1 June 1984
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 20 (6), 1239-1242
- https://doi.org/10.1016/0022-4731(84)90151-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Maternal Stress Decreases Steroid Aromatase Activity in Brains of Male and Female Rat FetusesNeuroendocrinology, 1982
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Cancer of the BreastNew England Journal of Medicine, 1980
- Cancer of the BreastNew England Journal of Medicine, 1980
- Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*Journal of Clinical Endocrinology & Metabolism, 1979
- Stereoselective Inhibition of Aromatase by Enantiomers of Aminoglutethimide*Endocrinology, 1979
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11Endocrinology, 1977
- Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivativesBiochemistry, 1976
- A dose response evaluation of delta‐1‐testololactone in advanced breast cancerCancer, 1974